TY - JOUR
T1 - Barcoding heat shock proteins to human diseases
T2 - looking beyond the heat shock response
AU - Kakkar, Vaishali
AU - Meister-Broekema, Melanie
AU - Minoia, Melania
AU - Carra, Serena
AU - Kampinga, Harm H.
PY - 2014/4
Y1 - 2014/4
N2 - There are numerous human diseases that are associated with protein misfolding and the formation of toxic protein aggregates. Activating the heat shock response (HSR) - and thus generally restoring the disturbed protein homeostasis associated with such diseases - has often been suggested as a therapeutic strategy. However, most data on activating the HSR or its downstream targets in mouse models of diseases associated with aggregate formation have been rather disappointing. The human chaperonome consists of many more heat shock proteins (HSPs) that are not regulated by the HSR, however, and researchers are now focusing on these as potential therapeutic targets. In this Review, we summarize the existing literature on a set of aggregation diseases and propose that each of them can be characterized or `barcoded' by a different set of HSPs that can rescue specific types of aggregation. Some of these 'non-canonical' HSPs have demonstrated effectiveness in vivo, in mouse models of protein-aggregation disease. Interestingly, several of these HSPs also cause diseases when mutated - so-called chaperonopathies - which are also discussed in this Review.
AB - There are numerous human diseases that are associated with protein misfolding and the formation of toxic protein aggregates. Activating the heat shock response (HSR) - and thus generally restoring the disturbed protein homeostasis associated with such diseases - has often been suggested as a therapeutic strategy. However, most data on activating the HSR or its downstream targets in mouse models of diseases associated with aggregate formation have been rather disappointing. The human chaperonome consists of many more heat shock proteins (HSPs) that are not regulated by the HSR, however, and researchers are now focusing on these as potential therapeutic targets. In this Review, we summarize the existing literature on a set of aggregation diseases and propose that each of them can be characterized or `barcoded' by a different set of HSPs that can rescue specific types of aggregation. Some of these 'non-canonical' HSPs have demonstrated effectiveness in vivo, in mouse models of protein-aggregation disease. Interestingly, several of these HSPs also cause diseases when mutated - so-called chaperonopathies - which are also discussed in this Review.
KW - Chaperonopathies
KW - Heat shock protein
KW - Protein-aggregation diseases
KW - AMYOTROPHIC-LATERAL-SCLEROSIS
KW - ALPHA-B-CRYSTALLIN
KW - UBIQUITIN-PROTEASOME SYSTEM
KW - RECESSIVE SPASTIC ATAXIA
KW - TRANSGENIC MOUSE MODEL
KW - BARDET-BIEDL-SYNDROME
KW - POLYGLUTAMINE-INDUCED NEURODEGENERATION
KW - SYNUCLEIN-INDUCED TOXICITY
KW - AGGREGATION IN-VITRO
KW - MOLECULAR CHAPERONES
U2 - 10.1242/dmm.014563
DO - 10.1242/dmm.014563
M3 - Review article
C2 - 24719117
SN - 1754-8403
VL - 7
SP - 421
EP - 434
JO - Disease models & mechanisms
JF - Disease models & mechanisms
IS - 4
ER -